To Target Liver Disease, VCU Researcher Turns to a Molecule Our Bodies Already Have
September 17, 2026
September 17, 2026
RICHMOND, Virginia, Sept. 17 -- Virginia Commonwealth University issued the following news:
* * *
Sept. 16, 2026
To target liver disease, VCU researcher turns to a molecule our bodies already have
Yaping Wang is advancing cholestenoic acid to treat the global menace of MASLD and potentially other conditions.
By John Battiston
When Yaping Wang tells people that the compound she is developing as a liver disease therapy i . . .
* * *
Sept. 16, 2026
To target liver disease, VCU researcher turns to a molecule our bodies already have
Yaping Wang is advancing cholestenoic acid to treat the global menace of MASLD and potentially other conditions.
By John Battiston
When Yaping Wang tells people that the compound she is developing as a liver disease therapy i . . .